A full-standby seller note is a seller loan on which you pay no principal and no interest for the entire life of the SBA loan, and in exchange it can count toward your SBA equity injection. As of October 2026, under SBA SOP 50 10 8.1, standby notes and other limited sources can supply no more than half of the 10% injection, so on a $2.5 million project the note can cover at most $125,000. Sellers resist because they wait years for payment and sit behind the bank.
The mechanics under SBA SOP 50 10 8.1, which applies to loans receiving an SBA loan number on or after October 1, 2026:
The 10% is measured on total project costs: purchase price plus working capital, fees and closing costs. It is not 10% of the price alone. For an Initial Acquisition, it cannot be reduced.
From the seller's chair, a full-standby note is the least attractive kind of paper. The reasons are concrete:
Accept those objections as fair. They are. The question is whether the note is small enough, and the price good enough, that the seller still comes out ahead.
An Initial Acquisition, with illustrative inputs:
Now compare a note that is not on standby. A $125,000 note at 7% over 10 years costs $1,451.36 a month, or $17,416 a year. The lender must add that to debt service, and the note no longer counts toward the injection. You would need the full $250,000 from other sources, usually your cash, and coverage would be tighter. The standby structure saves you $125,000 of cash at closing. The seller pays for that saving in time and risk.
Two more checks apply. The SBA requires an independent business valuation on every change-of-ownership loan, and total debt is capped at the appraised value. A higher price to compensate the seller for standby only works if the appraisal supports it; any gap between price and valuation comes from your cash. At this price, no lender-commissioned Quality of Earnings report is required; that rule starts at a $3 million purchase price for Initial Acquisitions.
Where these numbers come from: Standby, limited-source, injection, valuation, QoE and consulting rules are from SBA SOP 50 10 8.1 as summarized by Beancount, Cantrell Firm and FunderIntel; the injection background is from Starfield & Smith. The $5 million cap is from the SBA. Cash-at-close data is from the IBBA Market Pulse Q2 2026. Payments are standard amortization arithmetic. SOP 50 10 8.1 applies to loans that receive an SBA loan number on or after October 1, 2026 (SBA Information Notice 5000-880695).
No. Every seller note in an SBA deal sits behind the bank. Full standby goes further: nothing is paid at all while the SBA loan is outstanding. A subordinated note that pays on schedule is counted in your coverage test instead.
No. Under SOP 50 10 8.1, limited sources together can supply at most half. The pre-June-2025 "zero down" approach is gone.
A sale would normally pay off the SBA loan, which ends the standby period. The note's own terms then govern payment. Have counsel draft what happens on a sale or refinance.
Yes, in the sense that it adds no payments while the SBA loan is outstanding. A note that pays on schedule must be included in coverage at a maximum 10-year amortization.
If the seller will not carry enough on standby, the other half of the injection has to come from you or from investors. See whether investors can fund your down payment and what you give up.
Meraki Dealmakers is a service of Meraki Partners, LLC, an advisory firm. It is not a broker-dealer, investment adviser, business broker, law firm or accounting firm. This article is general information, not legal, tax or investment advice.
Start with the playbook. The first conversation is free.
Meraki Dealmakers is a service of Meraki Partners, LLC.
Meraki Partners, LLC is an advisory firm. It is not a broker-dealer, investment adviser, business broker, law firm or accounting firm, and does not solicit investors or receive compensation based on capital raised.
© 2026 Meraki Partners, LLC